14 articles for J Ellingboe
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Design, synthesis, and evaluation of (2S,4R)-Ketoconazole sulfonamide analogs as potential treatments for Metabolic Syndrome.

Temple University
Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.

Wyeth Research
Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.

Wyeth Research
(4-Piperidin-1-yl)phenyl amides: potent and selective human beta(3) agonists.

Wyeth-Ayerst Research
Novel benzofuran derivatives with dual 5-HT1A receptor and serotonin transporter affinity.

Wyeth Research
Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.

Wyeth Research
Synthesis and SAR of bis-statine based peptides as BACE 1 inhibitors.

Wyeth Research
New oxadiazolidinedione derivatives as potent and selective human beta3 agonists.

Wyeth-Ayerst Research
2,4-Thiazolidinediones as potent and selective human beta3 agonists.

Wyeth-Ayerst Research
Design and synthesis of functionalized piperazin-1yl-(E)-stilbenes as inhibitors of 17α-hydroxylase-C17,20-lyase (Cyp17).

Temple University
(Pyrimidinyloxy)acetic acids and pyrimidineacetic acids as a novel class of aldose reductase inhibitors.

Wyeth-Ayerst Research
Inhibitors of RET

Blueprint Medicines
Structure-guided design of pyrazolo[1,5-a]pyrimidines as inhibitors of human cyclin-dependent kinase 2.

Vernalis (R&D)
Effectiveness of nonpeptide clinical inhibitor TMC-114 on HIV-1 protease with highly drug resistant mutations D30N, I50V, and L90M.

Georgia State University